Krishna Institute of Medical Sciences Ltd

- The company is investing heavily in growth projects including Bangalore, Nashik, and Thane hospitals. - Capex for FY2024 is expected around Rs. 650-700 Crores (250 Crores for Bangalore & Nashik, 250 Crores approx. for Thane if asset-heavy). - Discussions are ongoing with institutional investors for an asset-light model for the Thane project to reduce on-balance sheet Capex (~250 Crores reduction if successful). - Current net debt is roughly Rs. 300 Crores, with a comfortable debt-to-EBITDA ratio guidance of 1.5 to 1.75 times. - The company is generating strong cash flows (~Rs. 400 Crores annually) and plans to deploy this cash for growth, with some possibility of front-loaded debt depending on project structures. - Overall, any additional debt or equity raise will depend on finalizing asset-light deals primarily for the Thane project. No explicit mention of new equity fundraising so far.

- Ongoing Capex projects in Bangalore and Nashik, with approximately ₹250 Crores remaining, aiming for operationalization by Q1 FY2025 with initial 150 beds each. - Capex of around ₹100 Crores planned for oncology bed additions, gas flow units, mother & child units, and relevant equipment at existing units. - Thane hospital project (300 beds) with estimated total cost between ₹400-450 Crores; discussions ongoing for an asset-light model by involving institutional investors to reduce Capex on books by ₹250 Crores. - Sunshine Hospital buyout involving Capex for building acquisition ongoing. - Vizag hospital expansion (25 beds) operational in FY2024; Sunshine relocation with no new bed addition. - Focus on continuous growth with consolidation in current geographies before further expansion. - Capex expected to drive margin expansion and capacity growth over 3-6 years with ramp-up plans phased as occupancy improves.

- KIMS aims to continue its growth trajectory with optimism, critically evaluating new opportunities for expansion and value addition. - Existing Telangana and Andhra Pradesh mature assets have headroom for growth; Telangana Secunderabad is at 70% occupancy with room to grow over the next two years. - Bed additions planned in FY2025 (e.g., Kondapur expansion) and FY2026 from mature Telangana and AP markets. - New hospital facilities like Thane (300 beds) and Nashik (initial 150 operational beds out of capacity for 250-300 beds) expected to contribute to revenue growth. - Gradual ramp-up of doctor strength by 12-15 in next 6-9 months to increase patient flow and revenue. - Newly acquired Nagpur facility expected to improve EBITDA margin to 10-12% within 6-8 months. - Revenue growth driven by incremental clinician additions and phased hospital capacity activation. - Expansion focused on consolidating positions in current geographies before entering new ones.

- The company expects to continue growth on the same trajectory with a positive and optimistic outlook. - EBITDA margins are projected to improve, with some facilities expecting margin profile changes after new clinicians join. - Incremental revenue growth is anticipated from hospital expansions and new doctor recruitments, e.g., a potential Rs. 7-8 Crores incremental revenue at Begumpet. - Telangana assets expect high single-digit EBITDA growth, with new specialties and bed capacity expansions supporting this. - Consolidated EBITDA margins improved recently, indicating operational efficiency gains. - EPS showed strong growth of 15.6% YoY and 22.8% QoQ in recent quarters. - Management expects stabilization periods of 6-9 months for new assets, with leadership recruitment as a priority for sustained growth. - Long-term ROIC targets around 25% margins and asset turnover of 1-1.25 times per bed. - Focus on organic growth from existing mature assets and strategic new acquisitions to drive future profit growth.

- The transcript provided does not explicitly mention the current or expected order book or pending orders for KIMS Hospitals. - The discussion mainly focuses on operational updates, expansions, bed capacity additions, margin improvements, and strategic plans. - Key expansions include adding beds in Telangana (from 1200 to ~2000), Andhra Pradesh (from 645 to ~1200), new hospitals planned in Bangalore, Nashik, and Thane slated for FY2025. - Nagpur and Sunshine hospital operational and margin progress discussed, but no explicit order book details. - Capital expenditure plans mentioned: ₹250 Crores for Thane, ₹350 Crores ongoing for Nashik and Bangalore in FY2024. - No direct references to order book values or pending orders are made in the document excerpts provided.